IFPMA Position Paper on Pharmacovigilance Principles for Biotherapeutic Medicines

Statement 9 Jun 2026

UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR)

IFPMA statement at the UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR) in New York on 9 June. We share the same objective: a world better prepared to prevent, prepare for, detect, and respond to pandemics. Industry is a core part of that system, engaging in strengthening the health of populations, developing vaccines...

Pharmaceutical industry’s response to the Ebola Bundibugyo virus disease outbreak

The latest Ebola Bundibugyo outbreak in Democratic Republic of Congo, Uganda, and neighbouring countries is deeply concerning. Pharmaceutical and biotech companies are working with global partners in a coordinated response. Accelerating the response As the scientific, humanitarian, and global health response accelerates to contain the outbreak, pharmaceutical companies remain central to these efforts. While no...

IFPMA Note for Guidance on educational and scientific events (2026 update)

Collaborations between healthcare professionals (HCPs) and the pharmaceutical industry are essential and ensure that patients have access to the medicines they need and that healthcare professionals have up-to-date comprehensive information about the diseases they treat and the medicines they prescribe.